←Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Immunotherapy
Mario Sznol
MD
🏢Yale School of Medicine🌐USA
Professor of Medicine, Medical Oncology
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mario Sznol was among the earliest investigators of nivolumab in melanoma and helped lead CheckMate-067 establishing nivolumab plus ipilimumab as a standard of care. He has been a leader in checkpoint inhibitor clinical development at Yale.
Share:
🧪Research Fields 研究领域
nivolumab melanoma
checkpoint inhibitor development
CheckMate-067
early immunotherapy trials
immune biomarkers
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mario Sznol 的研究动态
Follow Mario Sznol's research updates
留下邮箱，当我们发布与 Mario Sznol（Yale School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment